NCT00520052 Frequency of Zoledronic Acid to Prevent Further Bone Loss in Osteoporotic Patients Requiring Androgen Deprivation Therapy for Prostate Cancer Status COMPLETED Phase NA
NCT00518765 Hemodynamic Effects of Aliskiren Compared to Captopril on the Kidney in Healthy Volunteers on a Low- and High- Sodium Diet Status COMPLETED Phase PHASE3
NCT00515424 Tolerability, Safety and Efficacy of RKI983 Eye Drops in Subjects With Primary Open Angle Glaucoma and Ocular Hypertension Status COMPLETED Phase PHASE1
NCT00514488 Imatinib Standard Dose (400 mg/Day) Versus Imatinib High Dose (800 mg/Day) Status COMPLETED Phase PHASE3
NCT00513487 Effects of Multiple Nasal Exposures to House Dust Mite Allergen on Nasal and Body Inflammation and Airway Sensitivity Status COMPLETED Phase NA
NCT00512499 Strategies to Treat Osteoporosis Following a Fragility Fracture Status COMPLETED Phase NA
NCT00512213 Immunonutrition Versus Standard Enteral Nutrition Before Major Surgery Status COMPLETED Phase NA
NCT00511771 A Treatment Investigational New Drug (tIND) Program of Tegaserod in Women With Irritable Bowel Syndrome With Constipation or With Chronic Idiopathic Constipation Status NO_LONGER_AVAILABLE Phase N/A
NCT00511303 Protein-Tyrosine Kinase Inhibitor (STI571) for Treatment of Patients With Ph+ Chronic Myeloid Leukemia Status COMPLETED Phase PHASE2
NCT00511121 Study of the Combination of a Tyrosine Kinase Inhibitor (STI571) and a Pegylated Human Recombinant Interferon alfa2b (PEGINTRON) Status TERMINATED Phase PHASE2
NCT00510965 Ranibizumab to Treat Choroidal Neovascularization (CNV) in Patients With Pseudoxanthoma Elasticum (PXE) Status COMPLETED Phase PHASE2
NCT00510510 Safety and Tolerability of 28 Days Treatment With Glycopyrronium Bromide (NVA237) (100 or 200 µg Once a Day) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease Status COMPLETED Phase PHASE2
NCT00510224 Sandostatin for Patients With Androgen Independent Prostate Cancer Status TERMINATED Phase PHASE2
NCT00505089 Efficacy and Safety of Subcutaneous Versus Intravenous ACZ885 in Adult Patients With Established Rheumatoid Arthritis Status TERMINATED Phase PHASE1/PHASE2
NCT00504959 Safety and Tolerability of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration Status COMPLETED Phase PHASE4
NCT00504595 Safety and Efficacy of ACZ885 in Adult Patients With Established Rheumatoid Arthritis Status COMPLETED Phase PHASE2
NCT00504400 Ranibizumab to Treat Type 2 Idiopathic Macular Telangiectasia (RAMA-Trial) Status COMPLETED Phase PHASE2
NCT00503360 Tolerability, Safety and Efficacy of SAD448 in Subjects With Ocular Hypertension Status COMPLETED Phase PHASE1